5 Starliving Online Inc. Announces Pending Ticker Symbol Change to "VRAL".Business Editors SOUTH PASADENA, Calif.--(BUSINESS WIRE)--Nov. 15, 2001 5 Starliving Online Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :HTHV), which is changing its name to Viral Genetics Inc. pursuant to its acquisition of the California company of the same name, recently received notice from the NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). relating to its request for a new trading symbol. Effective simultaneously with the name change on November 20, 2001, the common shares of Viral Genetics Inc. will trade under the symbol VRAL on the Over-the-Counter Bulletin Board market. Viral Genetics, Inc., a development-stage California Corporation, was founded in 1995 to discover, develop and commercialize therapeutic and diagnostic systems for the treatment of viral diseases. Viral Genetics has completed human clinical trials of its primary product, TNP TNP The New Paper (Singapore newspaper) TNP Tratado de No Proliferación Nuclear (French) TNP Trattato di Non Proliferazione Nucleare (Italian) - an HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome treatment, on HIV-infected and fulminant ful·mi·nant adj. Occurring suddenly, rapidly, and with great severity or intensity, usually of pain. ful AIDS multi-drug-cocktail-resistant patients in Mexico City, Mexico. This trial was administered under the authority and with the approval of the IMSS IMSS Instituto Mexicano del Seguro Social (Spanish: Mexican Social Security Institute) IMSS Istituto e Museo di Storia della Scienza (Italian) IMSS InterScan Messaging Security Suite - the department of the Mexican federal government's health and social services Ministry responsible for oversight of Mexico's socialized so·cial·ize v. so·cial·ized, so·cial·iz·ing, so·cial·iz·es v.tr. 1. To place under government or group ownership or control. 2. To make fit for companionship with others; make sociable. medical system, including the approval of human clinical trials. The company expects to apply for registration of TNP with the Minister of Health for the purposes of allowing its commercialization in Mexico during the fourth quarter of this year. Further information relating to the company's historical, ongoing and planned research activities is forthcoming. The company website is www.viral-genetics.com. Safe Harbor Statement under the Private Securities Reform Act of 1995: Except for the historical information herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties including, but not limited to economic, competitive, governmental and technological factors affecting the Company's operations, markets, products and prices, and other factors discussed in the Company's various filings with the Securities and Exchange Commission. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion